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Background: Lower habitual physical activity and poor cardiorespiratory fitness are common 
features of the metabolically abnormal obese (MAO) phenotype that contribute to increased 
cardiovascular disease risk. The aims of the present study were to determine 1) whether 
 community-based exercise training transitions MAO adults to metabolically healthy, and 
2) whether the odds of transition to metabolically healthy were larger for obese individuals who 
performed higher volumes of exercise and/or experienced greater increases in fitness.
Methods and results: Metabolic syndrome components were measured in 332 adults 
(190 women, 142 men) before and after a supervised 14-week community-based exercise pro-
gram designed to reduce cardiometabolic risk factors. Obese (body mass index 30 kg ⋅ m2) 
adults with two to four metabolic syndrome components were classified as MAO, whereas those 
with no or one component were classified as metabolically healthy but obese (MHO). After 
community exercise, 27/68 (40%) MAO individuals (P0.05) transitioned to metabolically 
healthy, increasing the total number of MHO persons by 73% (from 37 to 64). Compared with 
the lowest quartiles of relative energy expenditure and change in fitness, participants in the high-
est quartiles were 11.6 (95% confidence interval: 2.1–65.4; P0.05) and 7.5 (95% confidence 
interval: 1.5–37.5; P0.05) times more likely to transition from MAO to MHO, respectively.
Conclusion: Community-based exercise transitions MAO adults to metabolically healthy. 
MAO adults who engaged in higher volumes of exercise and experienced the greatest increase 
in fitness were significantly more likely to become metabolically healthy. Community exercise 
may be an effective model for primary prevention of cardiovascular disease.
Keywords: exercise, obesity, prevention, risk factors
Introduction
Despite current estimates indicating that ∼78 million US adults are obese, recent 
epidemiological data from the National Health and Nutrition Examination Survey 
(NHANES) suggest that a substantial portion of obese Americans are essentially 
metabolically healthy.1 This subset of obese individuals, often referred to as metaboli-
cally healthy but obese (MHO),2 appear to be more resistant to the adverse cardio-
metabolic consequences that their metabolically abnormal obese (MAO) peers often 
face.3,4 For example, recent findings from a large prospective study demonstrated 
that the risks of all-cause and cardiovascular disease (CVD) mortality were 57% and 
76% lower, respectively, in MHO compared with MAO adults.5 Although a universal 
definition of the MHO phenotype has not been established, it has been argued that 
the remarkable protection against CVD and diabetes observed in this population is 
partly attributed to favorable metabolic profiles. Indeed, the MHO phenotype is most 
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commonly characterized by preserved insulin sensitivity, 
normal blood pressure, and an absence of dyslipidemia, 
despite excess body fat.6–8 However, the precise physiologi-
cal and/or lifestyle factors that contribute to the protective 
metabolic characteristics in this subset of obese individuals 
are not completely understood.
Regular physical activity9,10 and higher cardiorespira-
tory fitness11–13 alleviate the adverse impacts of obesity on 
all-cause and CVD mortality through favorable modifica-
tions in cardiometabolic risk factors14,15 and reduced inci-
dence of metabolic syndrome (MetS).16,17 It is not surprising 
that greater habitual physical activity is thought to underlie 
the favorable metabolic profiles of the MHO phenotype. 
Indeed, both large-1 and small-scale18 observational stud-
ies indicate that physically active obese individuals more 
often display healthy metabolic profiles than less active 
obese individuals. In addition to greater physical activity, 
more recently it has been demonstrated that higher cardio-
respiratory fitness is an important underlying characteristic 
that also confers protection against cardiometabolic risk in 
MHO people.5,19 In a large cohort of the Aerobics Center 
Longitudinal Study, Ortega et al5 reported that MHO adults 
were significantly more fit than MAO adults. More impor-
tantly, when fitness was accounted for, the multivariate 
adjusted hazard ratios of all-cause and CVD mortality and 
incident nonfatal  atherosclerotic CVD events in the MHO 
cohort were similar to those of the normal-weight healthy 
subjects. Although these findings highlight the protective 
role of fitness with the MHO phenotype, they also present 
the notion that exercise programs designed to increase 
fitness may attenuate CVD risk in MAO persons. In fact, 
it has been reported that after adjustment for fitness, the 
risk of CVD mortality in MAO individuals was reduced 
by 32%.5 This finding provides scientific support for a 
beneficial effect of exercise in all subgroups of obesity 
regardless of risk factor burden.
The distinguishing physical activity and fitness attributes 
of the MHO phenotype prompt an intriguing question: can 
an exercise intervention that augments cardiorespiratory 
fitness transition MAO adults to metabolically healthy? We 
have previously demonstrated that individuals performing 
greater volumes of exercise as part of an evidence-based 
community exercise program were more likely to eliminate 
components of MetS.20 However, to date, no study has 
investigated whether a community-based exercise interven-
tion designed to increase exercise volume and fitness can 
transition MAO adults to an MHO phenotype. Identifying 
the therapeutic dose of exercise required to convert an MAO 
person to metabolically healthy would yield important 
 clinical information for the primary prevention of CVD in 
obese individuals. Therefore, the primary purpose of the 
present study was to determine 1) whether community-based 
exercise training transitions MAO adults to metabolically 
healthy, and 2) whether the odds of successful transition to 
metabolically healthy are larger for obese individuals who 
perform the highest volume of exercise and experience the 
greatest increase in fitness.
Methods
Study population
A total of 332 healthy community members (190 women, 
142 men; age range 28–88 years) included in the present 
study enrolled in the exercise program between January 2007 
and January 2012. All community members who participated 
in the exercise program were Caucasian. Before participa-
tion, all of the participants had the research study and its 
potential risks and benefits explained fully before providing 
written informed consent. This study was approved by the 
Institutional Review Board for the Protection of Human 
Subjects at the University of Wisconsin-Eau Claire, Eau 
Claire, WI, USA.
Pre-exercise health screening  
and assessment of cVD risk factors
Upon enrolment in the exercise program, participants under-
went a complete medical history and basic health assessment 
of traditional CVD risk factors to determine whether it was 
safe for them to engage in regular exercise. Information con-
cerning the use of medications, lifestyle and physical activity 
habits, and history or evidence of cardiovascular, pulmonary, 
or metabolic disease were documented.  Participants were 
excluded from the study if they presented with a history of 
cardiovascular, pulmonary, or metabolic disease. Select risk 
factors (age, sex, total cholesterol, high-density lipoprotein 
[HDL] cholesterol, smoking status, and systolic blood pres-
sure) were applied to the 10-year Framingham Risk Score 
algorithm to estimate future CVD risk before and after the 
exercise program. All pre-exercise measurements were sub-
sequently repeated after the 14-week exercise program.
Body composition and metabolic 
measurements
Body mass was measured using a Detecto medical beam 
 balance (Cardinal Scale Manufacturing Co, Webb City, MO, 
USA). Body mass index (BMI) was calculated as weight 
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(kilograms) divided by height (meters) squared. Abdominal 
obesity was estimated by minimal waist circumference mea-
sured at the smallest part of the abdomen at the highest part 
of the iliac crest to the nearest 0.1 cm at the end of normal 
expiration.21 Auscultatory resting systolic and diastolic blood 
pressure were measured using a stethoscope and sphygmo-
manometer (Diagnostic 700 Series; American Diagnostic 
Corporation, Hauppauge, NY, USA) following 5 minutes 
of seated quiet rest using standard procedures.22 Resting 
blood pressure measurements were performed twice on two 
separate occasions separated by a minimum of 48 hours. 
The mean of these two resting blood pressure measurements 
was recorded.
Following an overnight fast, a small sample of blood 
was taken from the index finger and analyzed for fasting 
plasma lipids, lipoproteins, and glucose concentrations 
using the Cholestech LDX System (Alere Inc., Waltham, 
MA, USA) under strict standardized operating procedures. 
Independent studies have provided data to indicate that the 
Cholestech LDX system has excellent reproducibility with 
standard clinical laboratory measurement of plasma lipids 
and lipoproteins,23,24 and meets the National Cholesterol Edu-
cation Program Adult Treatment Panel III (NCEP ATP III) 
criteria for accuracy and reproducibility.25
Cardiorespiratory fitness
To estimate maximal cardiorespiratory fitness, we admin-
istered conventional submaximal exercise test protocols 
(primarily walking or cycle ergometry protocols) using 
standardized procedures appropriate for middle-aged to 
older adults.26 Participants were instructed to refrain from 
exercising 24 hours prior to their scheduled exercise test. 
Submaximal exercise testing was completed in the morning 
hours following a light breakfast with adequate hydration. 
The submaximal test that was selected for participants was 
based on their training goals and whether they presented 
with musculoskeletal limitations that precluded the safe use 
of a particular test. Each participant completed the same 
submaximal exercise test at baseline and after the exercise 
program.
Definition of the metabolically healthy 
phenotypes
MHO individuals were identified if they presented with a 
BMI 30 kg/m2 and had no or one component of MetS. 
Our definition for MHO has been used elsewhere.4 MetS 
was established according to NCEP ATP III criteria.27,28 
The criteria include the following: 1) elevated triglycerides 
(150 mg/dL), 2) low HDL cholesterol (40 mg/dL in 
men and 50 mg/dL in women), 3) elevated blood pressure 
(systolic 130 mmHg and/or diastolic 85 mmHg), and 
4) elevated fasting glucose (100 mg/dL). Abdominal obesity 
(102 cm in men and 88 cm in women) was excluded, as 
the purpose of the study was to evaluate changes in metabolic 
health despite excess body fat. For example, a male subject 
with the following metabolic profile was considered MHO: 
triglycerides 140 mg/dL, HDL cholesterol 60 mg/dL, and 
blood pressure 140/80 mmHg. Metabolically healthy nonobese 
(MH-NO) participants were identified if they presented with a 
BMI 30 kg/m2 and had no or one MetS component.
Definition of the metabolically abnormal 
phenotypes
MAO individuals were identified if they presented with a 
BMI 30 kg/m2 and had two to four components of MetS. 
Similar to MHO, our definition for MAO has also been 
applied previously in the literature.4 For example, a female 
subject with the following metabolic profile would be con-
sidered MAO: triglycerides 170 mg/dL, HDL cholesterol 
50 mg/dL, and blood pressure 150/90 mmHg. Metabolically 
abnormal nonobese (MA-NO) participants were identified if 
they had a BMI 30 kg/m2 and presented with two to four 
components of MetS.
evidence-based community exercise 
programming
The community program provides an opportunity for mem-
bers of the local community to participate in individualized 
exercise for 14 weeks using established guidelines for exer-
cise frequency, intensity, and duration, under the guidance 
and supervision of qualified exercise professionals. A unique 
feature of the community-based program, which utilizes 
published data of randomized controlled clinical trials to 
individualize exercise programming, is its evidence-based 
practice approach. Specifically, the exercise prescription 
was based on Studies of a Targeted Risk Reduction Inter-
vention Through Defined Exercise (STRRIDE), which 
demonstrated greater improvements in cardiovascular risk 
factors with increasing doses of moderate-intensity exercise, 
expressed as relative exercise energy expenditure (EE) 
(14–23 kcal ⋅ kg-1 body weight per week).29 As such, each 
participant was provided with an individualized weekly EE 
goal of 14–23 kcal ⋅ kg-1 ⋅ week-1. The EE goal was used to 
calculate a minimum weekly exercise duration necessary to 
reduce CVD risk (corresponding to 40%–60% target VO
2
 
reserve) using the following calculation:
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Minimum minutes of exercise per week  
 = [14 kcal ⋅ kg-1 ⋅ week-1 × participant body mass]  
 ÷ [(40% target VO
2
 reserve work load × participant  
  body mass) ÷ 1,000 × 5 kcal L ⋅ O
2
-1].
Exercise volume (minutes/week) was then divided by 
the target frequency goal for each participant to obtain daily 
exercise duration. The maximum minutes of exercise per 
week, reflected by 60% VO
2
 reserve and 23 ⋅ kcal kg-1 ⋅ week-1, 
was also determined. Each member consulted with a team 
of exercise professionals and was assigned a University of 
Wisconsin-Eau Claire Department of Kinesiology senior 
student, who served as their exercise trainer. The trainers 
worked directly under the supervision of qualified PhD-
trained exercise physiologists. Members engaged in their 
morning exercise 3 days per week between 5.30 am and 8 am 
for 14 weeks via brisk walking, water aerobics, stationary 
cycling, or crosstraining. At the beginning of each exercise 
session, trainers met with their respective community mem-
ber to go over the morning exercise activities. The trainers 
coached members during their exercise sessions, provided 
motivational support, engaged in spotting, and corrected 
exercise technique. The student trainers also adjusted exercise 
intensities, modes, and durations with consultation from the 
exercise physiologists. Exercise progression and adherence 
were tracked by the use of daily exercise logs. In addition 
to tracking exercise frequency, intensity, and duration, the 
logs documented resting and exercise heart rate, ratings of 
perceived exertion, exercise time, metabolic equivalents, EE, 
target intensities, exercise modes, as well as the repetitions, 
sets, and exercises of their respective strength training routine. 
Log data were stored and saved in a FileMaker Pro database 
software program (FileMaker Pro, Santa Claire, CA).
Statistical analysis
All analyses were performed using Statistical Package 
for the Social Sciences, Version 19.0 (IBM Corporation, 
Armonk, NY, USA). All variables were initially checked 
for  normality. Measures of centrality and spread are pre-
sented as frequency and mean ± standard deviation. Mean 
differences in all outcome variables between baseline and 
postprogram were assessed using paired t-tests. Mean dif-
ferences in the transition from MAO to MHO were assessed 
using independent t-tests. The number of individual MetS 
components and the categorization of MHO or MAO 
were according to the NCEP ATP III guidelines.27 Chi-
square tests were used to analyze the point prevalence of 
metabolically abnormal individuals (ie, MAO and MA-NO) 
who successfully transitioned to metabolically healthy (ie, 
MHO and MH-NO) between baseline and postprogram.
Dichotomous variables were created to define those indi-
viduals who successfully transitioned from MAO to MHO (or 
from MA-NO to MH-NO) compared with those individuals 
who experienced no phenotype transition: 0= no transition 
from MAO to MHO; 1= positive transition from MAO to 
MHO. Low cardiorespiratory fitness was also identified as 
a risk factor.30 Individuals in the lowest 25th percentile rank 
according to age and sex were categorized as unfit.26 The 
same coding scheme used for the transition between MAO 
to MHO was also applied to changes in cardiorespiratory 
fitness status. Logistic regression was then performed to 
model the odds (±95% confidence interval [CI]) of transi-
tion between phenotype on relative EE status (inserted into 
the model as a categorical variable according to relative EE 
quartiles), adjusting for age and sex. Logistic regression was 
also used to model the percentage fitness change status and 
was inserted into the model as percentage fitness change 
quartiles. The level of statistical significance was set at 
P0.05 for all analyses.
Results
All subjects completed the 14-week exercise program 
without incident, although, as expected, there was vari-
ability in the volume of exercise among participants. The 
mean exercise intensity for the total cohort was 42% VO
2
 
reserve, with no differences between the obese or nonobese 
phenotypes. Baseline point prevalence of obese persons in 
the community exercise cohort was 31% (104/332). Of these, 
∼65% (n=68) were identified as MAO and 35% (n=37) were 
identified as MHO.
community exercise and obese 
phenotypes
Community exercise favorably impacted cardiometabolic 
risk factors in the obese cohort, irrespective of phenotype 
(Tables 1 and 2). Importantly, however, a significant por-
tion of MAO adults successfully transitioned to an MHO 
phenotype after community exercise. As a result, the point 
prevalence of MAO adults dropped significantly (P0.05) 
after exercise training as 40% (n=27) transitioned to 
metabolically healthy, increasing the total number of MHO 
persons by 73% (from 37 to 64). Table 1 presents baseline 
and postprogram health outcomes for the MAO subjects 
who successfully transitioned to metabolically healthy. 
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Table 1 Baseline and postprogram characteristics of the MaO and Ma-nO phenotype groups who transitioned to metabolically 
healthy (values are mean ± standard deviation)
Outcome variable MAO to MHO  
(n=27)
MA-NO to MH-NO  
(n=15)
Baseline Postprogram Baseline Postprogram 
absolute ee (kcal ⋅ wk-1) 371±512 1,770±552* 643±549 1,425±315*
relative ee (kcal ⋅ kg-1 ⋅ wk-1) 3.7±5.0 17.9±5.5* 8.6±7.6 19.4±5.2*
Waist circumference (cm) 112.0±13.0 109.3±12.5* 89.2±6.9 88.0±7.1
Body mass index (kg/m2) 34.1±3.8 34.0±3.7 25.4±3.1 25.3±3.2
Body mass (kg) 101.9±17.9 101.4±17.5 75.3±8.0 74.8±8.0
Systolic BP (mmhg) 126±11 120±9* 122±11 119±8
Diastolic BP (mmhg) 78±7 76±7* 75±9 75±7
Total cholesterol (mmol ⋅ l-1) 4.8±1.2 4.8±1.1 4.7±1.3 4.6±1.1
hDl cholesterol (mmol ⋅ l-1) 1.0±0.3 1.1±0.3* 1.0±0.2 1.1±0.3*
lDl cholesterol (mmol ⋅ l-1) 2.8±1.0 2.7±0.9 3.1±1.1 3.0±0.9
Triglycerides (mmol ⋅ l-1) 2.0±0.9 1.7±0.8* 1.5±0.7 1.4±0.4
glucose (mmol ⋅ l-1) 5.9±0.9 5.4±0.6* 6.3±0.8 5.5±0.5*
CR fitness (mL ⋅ kg-1 ⋅ min-1) 28.4±7.8 32.0±8.6* 32.2±5.5 36.6±6.8*
10-year risk score (%) 5.5±5.5 5.1±5.2 5.1±7.0 4.7±6.9*
Note: *P0.05 for within-group change versus baseline by paired t-test.
Abbreviations: BP, blood pressure; cr, cardiorespiratory; ee, energy expenditure; hDl, high-density lipoprotein; lDl, low-density lipoprotein; Ma-nO, metabolically 
abnormal nonobese; MaO, metabolically abnormal obese; Mh-nO, metabolically healthy nonobese; MhO, metabolically healthy obese.
Table 2 Baseline and postprogram characteristics of the obese and nonobese phenotypes who did not transition (values are mean ± 
standard deviation)
Outcome variable Obese (no transition) Nonobese (no transition)
MHO 
n=37
MAO 
n=41
MH-NO 
n=200
MA-NO 
n=9
Baseline Postprogram Baseline Postprogram Baseline Postprogram Baseline Postprogram 
absolute ee  
(kcal ⋅ wk-1)
438±512 1,422±381* 438±519 1,927±615* 492±488 1,371±483* 661±475 1,045±164
relative ee  
(kcal ⋅ kg-1 ⋅ wk-1)
4.8±5.4 15.8±3.8* 4.2±5.2 17.7±5.2* 6.2±6.3 17.1±6.2* 8.5±5.9 13.4±1.7
Waist circumference  
(cm)
102.3±12.2 100.1±12.5* 118.2±13.7 116.6±13.6* 92.6±19.0 91.6±18.2* 90.4±7.4 89.2±8.0*
Body mass index  
(kg/m2)
34.5±3.4 34.2±3.4* 35.1±4.0 34.9±4.0 26.7±1.9 26.6±1.9* 26.1±3.4 25.8±3.2
Body mass (kg) 91.7±16.4 90.7±15.8* 110.7±17.5 110.1±17.7 82.8±19.9 82.3±19.8* 79.1±8.6 78.3±8.5
Systolic BP (mmhg) 120±10 118±7* 131±13 125±11* 118±10 116±10* 128±17 120±19*
Diastolic BP (mmhg) 76±7 73±7 80±9 76±0.9* 74±8 73±7 81±14 76±14*
Total cholesterol  
(mmol ⋅ l-1)
5.0±1.1 4.9±0.9 4.8±1.2 4.6±0.2* 4.8±1.0 4.8±1.0 4.7±1.7 4.6±1.5
hDl cholesterol  
(mmol ⋅ l-1)
1.3±0.4 1.4±0.3* 0.8±0.3 0.9±0.8* 1.4±0.4 1.5±14* 0.9±0.4 1.0±0.3
lDl cholesterol  
(mmol ⋅ l-1)
3.0±1.0 2.9±0.8* 2.9±0.9 2.9±0.8 2.9±0.9 2.8±0.9* 3.5±1.4 3.3±1.3
Triglycerides  
(mmol ⋅ l-1)
1.4±0.7 1.3±0.6 2.4±1.1 2.0±0.8* 1.1±0.5 1.1±0.4 2.3±0.7 2.2±0.6
glucose (mmol ⋅ l-1) 5.8±0.9 5.6±0.8* 6.7±1.4 6.3±1.2* 5.4±1.1 5.3±0.9* 6.3±0.9 5.8±0.6
CR fitness  
(ml ⋅ kg-1 ⋅ min-1)
25.1±7.0 27.6±7.6* 29.0±8.7 32.2±9.0* 33.1±8.4 36.1±8.8* 29.5±8.0 31.8±7.0
10-year risk score (%) 1.5±2.6 1.5±2.3 6.7±6.4 6.1±5.4 5.4±6.3 4.7±5.5* 5.4±4.3 4.6±3.7*
Note: *P0.05 for within-group change versus baseline by paired t-test.
Abbreviations: BP, blood pressure; cr, cardiorespiratory; ee, energy expenditure; hDl, high-density lipoprotein; lDl, low-density lipoprotein; Ma-nO, metabolically 
abnormal nonobese; MaO, metabolically abnormal obese; Mh-nO, metabolically healthy nonobese; MhO, metabolically healthy obese.
 
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
374
Dalleck et al
40
30
20
10
*
**
*
*
*
0
40
A B
30
Before community exercise
After community exercise
20
M
et
ab
o
lic
 s
yn
d
ro
m
e 
ri
sk
 f
ac
to
rs
10
0
Elevated
blood pressure
Low
HDL-cholesterol
Elevated
triglycerides
Impaired
fasting glucose
Elevated
blood pressure
Low
HDL-cholesterol
Elevated
triglycerides
Impaired
fasting glucose
Figure 1 changes in point prevalence of metabolic syndrome risk factors before and after community exercise in the metabolically abnormal obese participants who 
transitioned to a metabolically healthy obese phenotype (A), and metabolically abnormal nonobese participants who transitioned to a metabolically healthy nonobese 
phenotype (B). 
Notes: *P0.05 versus before community exercise. Data analyzed using crosstabs Procedure, chi-square difference testing.
Abbreviations: hDl, high-density lipoprotein; lDl, low-density lipoprotein.
Paired t-tests revealed significant mean differences (P0.05) 
for all health outcomes, with the exception (P0.05) of 
BMI, body mass, total  cholesterol, LDL cholesterol, and 
10-year risk score. As shown in Figure 1A, the number of 
MAO people identified with low HDL cholesterol, elevated 
triglycerides, and impaired fasting glucose was reduced 
50%–74% postprogram. Impaired fasting blood glucose 
(n=14) was the most common MetS component eliminated. 
As a result of the successful transition in the MAO group, the 
point prevalence of MHO persons in the entire community 
cohort significantly increased (P0.05) from 11% to 19% 
after the exercise program.
The odds of phenotype transition across quartiles of 
relative EE and percentage change in cardiorespiratory 
fitness are shown in Figure 2. Logistic regression showed 
that compared with the lowest quartile (Q1) of relative EE, 
participants in the highest quartile (Q4) were 11.6 (95% CI 
2.1–65.4; P0.05) times more likely to transition from MAO 
to MHO (Figure 2 top panel). Similarly, logistic regression 
showed that compared with the lowest quartile (Q1) of per-
centage change in cardiorespiratory fitness, participants in the 
highest quartile (Q4) were 7.5 (95% CI 1.5–37.5; P0.05) 
times more likely to transition from MAO to MHO (Figure 2 
bottom panel).
Although a considerable portion of MAO people tran-
sitioned to a healthy obese phenotype, a number of MAO 
individuals (n=41) did not. Baseline and postprogram health 
outcomes for MAO individuals who did not transition are pre-
sented in Table 2. Similar to the MAO adults who transitioned 
to metabolically healthy (Table 1), MAO individuals who 
did not transition demonstrated significant mean reductions 
in all health outcomes after community exercise, with the 
exception of BMI, body mass, and LDL cholesterol (Table 2). 
Nevertheless, as shown in Figure 3A, there was no significant 
change in the point prevalence of MetS components after 
community exercise in this MAO subgroup.
All 36 of the MHO individuals identified at baseline 
remained metabolically healthy postprogram. Interestingly, 
although their baseline metabolic profiles were favorable 
as expected, community exercise participation still elicited 
significant improvements in all health outcomes, with the 
exception of diastolic blood pressure, total cholesterol, and 
triglycerides. In fact, as illustrated in Figure 3B, the number 
of MHO people who demonstrated one MetS risk factor at 
baseline was significantly reduced after community exercise. 
In particular, the number of MHO people with baseline 
elevated triglycerides (n=13) and impaired fasting glucose 
(n=21) was significantly reduced by 30% and 24% after 
the exercise program, respectively (Figure 3B; P0.05).
community exercise and nonobese 
phenotypes
Baseline point prevalence of nonobese persons in the commu-
nity exercise cohort was 67% (224/332). Within the nonobese 
group, ∼11% (n=24) were identified as MA-NO and 89% 
(n=200) were identified as MH-NO. Similar to the favorable 
effects of community exercise on metabolic profiles in the 
obese phenotype groups, several (n=15) MA-NO participants 
successfully transitioned to an MH-NO phenotype after com-
munity exercise. Indeed, paired t-tests revealed a significant 
decrease in 10-year CVD risk score, which was reflected by 
marked improvements in HDL cholesterol, cardiorespira-
tory fitness, and blood glucose concentrations (Table 1). 
Figure 1B shows the point prevalence of MetS components 
before and after community exercise in the MA-NO individu-
als who transitioned to metabolically healthy. The number 
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Abbreviation: VO2 max, maximal oxygen uptake.
of MA-NO people identified with elevated blood pressure, 
low HDL cholesterol, and impaired fasting glucose was 
significantly reduced postcommunity exercise. Impaired 
fasting blood glucose (n=11) was the most common MetS 
risk factor eliminated (Figure 1B). Given these beneficial 
phenotypic changes, the point prevalence of MA-NO adults 
in the entire community cohort dropped significantly (from 
7.2% to 4.5%; P0.05) postprogram as ∼63% (15/24) tran-
sitioned to metabolically healthy.
Baseline and postprogram health outcomes for the 
MA-NO individuals (n=9) who did not transition are pre-
sented in Table 2. MA-NO individuals who did not transition 
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demonstrated significant mean reductions in waist circumfer-
ence, blood pressure, and 10-year risk score postprogram. 
Aside from these favorable changes, there was no significant 
decrease in the point prevalence of MetS components after 
community exercise (Figure 3C).
All 200 of the MH-NO individuals identif ied at 
baseline remained metabolically healthy postprogram 
(Table 2).  Community exercise elicited significant, albeit mod-
est, improvements in all health outcomes, with the exception 
of diastolic blood pressure, total cholesterol, and triglycerides. 
The point prevalence of MH-NO people with low HDL choles-
terol at baseline significantly decreased after community exer-
cise (from 28 to 19; P0.05, Figure 3D). Likewise, the point 
prevalence of MH-NO people with impaired fasting glucose 
at baseline was also reduced (from 58 to 39; P0.05).
Discussion
The primary finding of the present study is that a short-
term community exercise intervention positively transitions 
individuals across the phenotypic spectrum from MAO 
to MHO, in part by eliminating components of MetS and 
increasing cardiorespiratory fitness. Indeed, the number of 
people identified with MAO was reduced by 40% following 
supervised community exercise, a finding that is supported 
by the 73% increase in the total number of MHO persons 
at program conclusion. Moreover, our findings suggest 
that higher volumes of exercise (expressed as relative EE) 
can substantially increase the likelihood that a person will 
transition from an MAO to an MHO phenotype. Although 
regular physical activity is thought to underpin the favorable 
metabolic profiles of the MHO phenotype, to our knowledge 
the impact of a community-wide physical activity interven-
tion to transition individuals from MAO to MHO has not 
been scientifically explored. As such, the results of this novel 
study are encouraging and support the tremendous potential 
to implement evidence-based exercise programming into 
the community to prevent obesity-related MetS, CVD, and 
mortality from CVD.
Current data exhibit that approximately 35% of American 
adults are obese.31 From a public health standpoint, it has 
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been well established that obese adults are at increased risk 
for developing type 2 diabetes, acute thrombotic events, such 
as myocardial infarction and stroke, and premature mortal-
ity when compared with their nonobese counterparts.32,33 
However, recent evidence has focused on the unique MHO 
phenotype subgroup of obese individuals who possess nor-
mal metabolic features despite increased adiposity, and who 
exhibit similar risk of mortality from all-cause and CVD to 
metabolically healthy normal-weight individuals.4  Previously, 
it has been reported from prospective cohort studies and 
observational epidemiological data that physical activity 
is a common attribute differentiating between the MHO 
and MAO phenotypes.1,18 The most striking finding of our 
study is that MAO adults who engaged in higher volumes of 
exercise were significantly more likely to become metaboli-
cally healthy. To our knowledge, we are the first to show that 
metabolic phenotype can be successfully transitioned through 
participation in a supervised community evidence-based 
exercise program. The fact that baseline MAO individuals 
who performed the highest  volume of relative EE (ie, 22.4 
kcal ⋅ kg-1 body weight per week) were nearly 12 times more 
likely to transition to the MHO phenotype represents an 
important clinical finding. Indeed, identification of the effica-
cious therapeutic dosage of exercise required to positively 
manage the MAO phenotype holds important implications 
for targeted preventive strategies. To this aim, our current 
findings provide important preliminary experimental exercise 
prescription data.
Although not included in the NCEP ATP III criteria for 
MetS, low cardiorespiratory fitness has been identified as a 
feature of the MetS17 and MAO phenotype.5 Moreover, in the 
past decade, being unfit has garnered considerable attention 
as an independent and powerful predictor of CVD risk and 
premature mortality. For example, Williams30 showed in a 
meta-analysis that there was a precipitous increase in relative 
risk for CVD in the lowest quartile of cardiorespiratory  fitness. 
More recently Blair34 estimated that low cardiorespiratory 
fitness accounted for more overall deaths when compared 
with deaths that could be attributed to traditional CVD risk 
factors, such as obesity, smoking, hypertension, high cho-
lesterol, and diabetes. In the present study, MAO adults who 
demonstrated the greatest improvements in cardiorespiratory 
fitness (ie, 20%) were significantly more likely to become 
metabolically healthy (Figure 2). Overall, cardiorespiratory 
fitness was improved, on average, more than one metabolic 
equivalent (1 MET =3.5 mL/kg/min) in the MAO to MHO 
phenotypic transition group following supervised community 
exercise. This improvement likely has important long-term 
 prevention implications, as a recent study reported that a one 
MET increase in  cardiorespiratory fitness was associated with 
an 18% reduction in deaths due to CVD.35
Well-designed studies examining the impact of commu-
nity-wide physical activity initiatives focusing on primary 
prevention of CVD in large groups of people, particularly 
people stratified to low or moderate risk, are limited. 
 However, it appears that renewed focus at the community and 
population levels aimed at increasing healthy behaviors and 
physical activity to eliminate cardiometabolic risk factors and 
positively transition individuals across the phenotypic spec-
trum should be a primary national public health concern.36 
Certainly, modest reductions in cardiometabolic risk factors 
that occur as a result of community initiatives will have large 
benefits in CVD prevention at the population level.37–39 For 
example, it has been demonstrated that a 1-year randomized 
study showing that a multiple risk factor community-based 
intervention trial (ie, risk factor reduction mediated by CVD 
counseling and physical activity opportunities on a community 
level) reduced 10-year coronary heart disease risk by ∼26% 
in high-risk black families compared with ∼3% with standard 
primary care.40 The significant reduction in risk was attrib-
uted, in part, to favorable modifications of MetS components. 
Indeed, ∼60% of subjects randomized to the community 
intervention eliminated high blood pressure as a risk factor 
and ∼50% eliminated high LDL cholesterol.  Furthermore, 
we have previously reported that a community exercise pro-
gram is an effective method to reduce cardiovascular risk in 
adults by substantially decreasing the prevalence of MetS and 
elimination of individual MetS components, most notably 
low HDL cholesterol and impaired fasting blood glucose.20 
These previous findings and results from the present study 
provide experimental support to implement community-wide 
primary prevention initiatives focusing on increasing physical 
activity to significantly reduce the burden of obesity and its 
associated comorbidities in the community.
It is well established that exercise-only interventions 
elicit modest weight loss reductions.41 Our findings across all 
phenotype groups corroborate these previous assessments. 
Comparatively, we did observe significant waist circumfer-
ence reductions in those individuals who transitioned from 
the MAO to the MHO phenotype. This observation has 
previously been reported elsewhere in the literature42 and 
mechanistically is of clinical significance, as abdominal 
obesity contributes to insulin resistance and a constellation 
of associated coronary heart disease risk factors, including 
dyslipidemia, elevated blood pressure, impaired fibrinoly-
sis, and chronic inflammation.31,43 High lipolytic rates are 
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commonly linked with abdominal obesity and subsequent 
impaired fatty acid oxidation.44 Moreover, a mismatch 
between free fatty acid uptake and oxidation has been shown 
to activate proinflammatory pathways within skeletal muscle 
that impair insulin action.45 In sum, decreased abdominal 
obesity coupled with lowered inflammation and improved 
insulin sensitivity are likely important mediating factors for 
transitioning individuals across the phenotypic spectrum 
from MAO to MHO.
Study limitations and strengths
There are a number of experimental considerations regard-
ing the present study. First, as with all retrospective stud-
ies, we cannot rule out the possibility that other factors 
(eg, medication use and lifestyle, dietary, and behavior 
changes) contributed to MAO to MHO phenotype transi-
tion, irrespective of the community exercise program. 
However, in an effort to minimize the influence of poten-
tial confounding lifestyle and pharmacological factors, 
we carefully included participants who were nonsmokers 
and free of overt cardiovascular and metabolic disease, as 
assessed by medical history. Our findings therefore should 
be viewed in the context of the sample population studied. 
Second, although the primary focus of the present study 
was on the effectiveness of community-based exercise 
training for transitioning MAO adults to an MHO pheno-
type, another important observation we encountered was 
the significant number of nonobese metabolically abnormal 
individuals who successfully transitioned to nonobese 
metabolically healthy. This phenotype transition likely 
has important primary prevention implications that merit 
further attention.
A major strength of the present study was the evidence-
based exercise program, which was modeled from pub-
lished data of randomized controlled trials that identified 
the optimal dose (ie, kcal ⋅ kg-1 body weight per week) and 
intensity (40%–60% VO
2
 reserve) of exercise to eliminate 
MetS components and thus elicit successful MAO to MHO 
phenotype transition in asymptomatic adults. In addition, 
the exercise program was personalized and carefully consid-
ered each participant’s goals, physical limitations, and risk 
 factors. We provided professional guidance and supervision, 
and periodically reviewed the program to ensure that it was 
meeting their health needs. Lastly, although the effectiveness 
of the exercise program to transition a significant number 
of MAO individuals to the MHO phenotype in a relatively 
short period of time (14 weeks) is a strength, perhaps even 
more individuals would have transitioned had the exercise 
program been extended. In particular, a longer exercise 
intervention may hold important clinical value for the 60% 
of MAO individuals in the present study who failed to transi-
tion to the MHO phenotype over the course of the exercise 
program. For example, the fact that the “no transition” MAO 
phenotype exhibited a significantly more severe risk factor 
profile at baseline is suggestive for the requirement of a 
longer exercise intervention.
Conclusion
In conclusion, these findings indicate that supervised com-
munity exercise can transition MAO adults to an MHO 
phenotype. MAO adults who engaged in higher volumes of 
exercise and those who demonstrated greater improvements 
in fitness were significantly more likely to become meta-
bolically healthy. Importantly, the unfavorable metabolic 
characteristics of obesity are not irreversible. Community 
exercise should be considered an effective model for the 
primary prevention of CVD in MAO adults. These results 
suggest that a community-based physical activity interven-
tion represents an enormous opportunity to reduce CVD 
risk and should be considered an effective model of primary 
prevention. Certainly, translating scientific evidence into 
action at the community level may help to restore enthusiasm 
for primary prevention on a national scale.
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